Premier Signs Multi-Source Agreement for Hypodermic and Sharps Products
HHS Awards $232 Million in Biodefense Contracts For Vaccine Development
California Health Officials Ask Health Individuals to Forego Flu Shots This Year Due to Vaccine Shortage
Shingles: A Replay of an Old Virus
GenoMed to Offer Nationwide Influenza Trial
Gene from 1918 Virus Proves Key to Virulent Influenza
A Study Showing EPIVIR-HBV(R) (lamivudine) Significantly Delays Liver Complications From Chronic Hepatitis B is Published by the New England Journal of Medicine
Joint Commission Launches Healthcare Staffing Services Certification Program
APIC Testifies Before HICPAC on Mandatory Reporting Issue
With Limited Flu Vaccine, Leading Infection Control Group Offers Preventive Tips
IDSA Urges Senate to Spur Anti-Infective Development
Stanford Scientists Help Bring Study Of Smallpox Virus Into 'Molecular Age'
Interim Influenza Vaccination Recommendations: 2004-05
New Biosensor Rapidly Detects Deadly Foodborne Pathogen
Joint Commission Issues Alert on Patient Awareness Under Anesthesia
HHS Issues Statement Regarding Chiron Flu Vaccine
Children Are Facing High Risks From Pesticide Poisoning
Flu Vaccine Needed to Protect Children Under Age Two
Pfizer to Acquire Purell From GOJO
Carrington Subsidiary Receives $6 Million Biodefense Grant to Develop Nasal Flu Vaccine
National Outbreak of Salmonella in United Kingdom
Spring-fall Flu Shots Safe, Protect Children
Mayo Clinic Awarded NIH Contract for Smallpox Genomics Research
Chiron Unable to Supply Fluvirin Influenza Virus Vaccine for 2004-2005 Season
Ohio Department of Health Ships Flu Vaccine to Local Health Departments
New York State Health, Agriculture and Markets Officials Issue Advisory About Illness Linked to Apple Cider
New Jersey Child Dies From Case of Bacterial Meningitis
Colorado Receives $150,000 to Assist With West Nile Virus Costs
Nurses Petition Federal Court to Stop Virginia Mason Medical Center's Mandatory Flu Vaccination Policy
Bristol-Myers Squibb Submits Applications in U.S. and Europe to Market Entecavir, an Investigational Antiviral Treatment For Chronic Hepatitis B Infection
